| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activity of IL-12/15/18 primed natural killer cells against hepatocellular carcinoma
|
Zhuang, Lihui
|
|
2018
|
13 |
1 |
p. 75-83
|
article
|
| 2 |
Antifibrotics in liver disease: are we getting closer to clinical use?
|
Bansal, Meena B.
|
|
2018
|
13 |
1 |
p. 25-39
|
article
|
| 3 |
Chinese guidelines on the management of ascites and its related complications in cirrhosis
|
Xu, Xiaoyuan
|
|
2019
|
13 |
1 |
p. 1-21
|
article
|
| 4 |
Correction to: Antifibrotics in liver disease: are we getting closer to clinical use?
|
Bansal, Meena B.
|
|
2019
|
13 |
1 |
p. 40-41
|
article
|
| 5 |
DAMPs and sterile inflammation in drug hepatotoxicity
|
Yang, Runkuan
|
|
2018
|
13 |
1 |
p. 42-50
|
article
|
| 6 |
Identifying barriers to treatment of HCV in the primary care setting
|
Johnson, Steve
|
|
2018
|
13 |
1 |
p. 58-65
|
article
|
| 7 |
New generation cancer therapy: right direction for sure with some uncertainty
|
Ueno, Yoshiyuki
|
|
2018
|
13 |
1 |
p. 22-24
|
article
|
| 8 |
Precision-cut liver slices: a versatile tool to advance liver research
|
Palma, Elena
|
|
2018
|
13 |
1 |
p. 51-57
|
article
|
| 9 |
Systematic review: diagnostic accuracy of non-invasive tests for staging liver fibrosis in autoimmune hepatitis
|
Wu, Shanshan
|
|
2018
|
13 |
1 |
p. 91-101
|
article
|
| 10 |
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort)
|
Gentile, Ivan
|
|
2018
|
13 |
1 |
p. 66-74
|
article
|
| 11 |
Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis
|
Iqbal, Umair
|
|
2018
|
13 |
1 |
p. 84-90
|
article
|
Journal description